IRX Therapeutics and Japan’s NCRC collaborate to evaluate peptide-based cancer vaccines
May 1, 2010 by AboutNanoWires.com · Leave a Comment
IRX Therapeutics and Japan’s NCRC collaborate to evaluate peptide-based cancer vaccines
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan’s National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen …
Read more on News-Medical-Net
